NovaBay Pharmaceuticals's book value per share for the quarter that ended in Dec. 2023 was $0.12.
During the past 12 months, NovaBay Pharmaceuticals's average Book Value Per Share Growth Rate was -96.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -77.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -42.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of NovaBay Pharmaceuticals was 58.70% per year. The lowest was -77.30% per year. And the median was -12.80% per year.
NovaBay Pharmaceuticals's current price is $0.077. Its book value per share for the quarter that ended in Dec. 2023 was $0.12. Hence, today's PB Ratio of NovaBay Pharmaceuticals is 0.64.
During the past 13 years, the highest P/B Ratio of NovaBay Pharmaceuticals was 108.47. The lowest was 0.20. And the median was 5.07.
NovaBay Pharmaceuticals Book Value per Share Historical Data
The historical data trend for NovaBay Pharmaceuticals's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, NovaBay Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovaBay Pharmaceuticals PB Ratio Distribution
For the Biotechnology industry and Healthcare sector, NovaBay Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where NovaBay Pharmaceuticals's PB Ratio falls into.
NovaBay Pharmaceuticals Book Value per Share Calculation
NovaBay Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
NovaBay Pharmaceuticals (AMEX:NBY) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
NovaBay Pharmaceuticals Book Value per Share Related Terms
Thank you for viewing the detailed overview of NovaBay Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
NovaBay Pharmaceuticals (NovaBay Pharmaceuticals) Business Description
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NBY has been successfully added to your 